February 11-14, 2008
All sessions and meal functions will be held at the St. Regis Monarch Beach Resort at One Monarch Beach, Dana Point, California, 92629 USA

Tuesday, February 12, 2008
8 am–12 pm		Concurrent Closed Working Group Meetings Groups Meeting: • Cellular & Molecular Basis of PAH • Genetics & Genomics of PAH • Diagnosis, Assessment & Treatment of Severe Non-PAH PH • End Points & Clinical Trial Design in PAH • Future Perspectives
12 pm–2 pm		Luncheon
2 pm–6 pm		Concurrent Closed Working Group Meetings Continued
Wednesday, February 13, 2008
8 am-12 pm		Plenary Session: Welcoming Remarks Robyn J. Barst (New York, New York, USA) and Lewis J. Rubin (La Jolla, California, USA), Steering Committee Co-chairs
		Task Force Reports and Discussion: Basic Science Marc Humbert (Clamart, France), Committee Chair • Development and Pathology Sheila G. Haworth (London, UK) and Rubin Tuder (Baltimore, Maryland, USA), Moderating • Classification and Epidemiology Ivan M. Robbins (Nashville, Tennessee, USA) and Gerald Simonneau (Clamart, France), Moderating • Inflammation, Growth Factors, and Pulmonary Vascular Remodeling Paul M. Hassoun (Baltimore, Maryland, USA) and Marc Humbert (Clamart, France), Moderating • Cellular and Molecular Basis of PAH Nicholas W. Morrell (Cambridge, UK) and E. Kenneth Weir (Minneapolis, Minnesota, USA), Moderating
12 pm-2 pm		Luncheon and Poster Presentations
2 pm-6 pm		Plenary Session: Task Force Reports and Discussion: Basic Science Marc Humbert (Clamart, France), Committee Chair • Genetics and Genomics of PAH John H. Newman (Nashville, Tennessee, USA) and Richard C. Trembath (Leicester, UK), Moderating Task Force Reports and Discussion: Clinical Science Vallerie V. McLaughlin (Ann Arbor, Michigan, USA), Committee Chair • Diagnosis and Assessment of PAH Adam Torbicki (Warsaw, Poland) and David B. Badesch (Denver, Colorado, USA), Moderating • Interventional and Surgical Modalities of Treatment in PAH Anne M. Keogh (Sydney, Australia) and Eckhard Mayer (Mainz, Germany), Moderating • Medical Treatment Robyn J. Barst (New York, New York, USA) and Nazzareno Galie (Bologna, Italy), Moderating
Thursday, February 14, 2008
8 am-12 pm		Plenary Session: Welcoming Remarks Robyn J. Barst (New York, New York, USA) and Lewis J. Rubin (La Jolla, California, USA), Steering Committee Co-chairs
		Task Force Reports and Discussion: Clinical Science Vallerie V. McLaughlin (Ann Arbor, Michigan, USA), Committee Chair • Diagnosis, Assessment, and Treatment of Severe Non-PAH PH Marius M. Hoeper (Hannover, Germany) and Michael D. McGoon (Rochester, Minnesota, USA), Moderating • End Points and Clinical Trial Design in PAH Vallerie V. McLaughlin (Ann Arbor, Michigan, USA) and Werner Seeger (Giessen, Germany), Moderating Task Force Reports and Discussion: Future Perspectives Lewis J. Rubin (La Jolla, California, USA) and Ardeschir Ghofrani (Giessen, Germany), Committee Co-chairs
12 pm-2 pm		Luncheon and Poster Presentations
2 pm		Adjournment